Nine years ago, Tim Baker was diagnosed with stage 4, metastatic prostate cancer. Today, astonishingly, he is fit and healthy, and meeting the scientists researching new treatments for this disease.
Academic rigour, journalistic flair
Articles on Prostate cancer
Displaying 1 - 20 of 73 articles
A new study looked at data from men for five years before a prostate cancer diagnosis, and five years afterwards, to understand how facing prostate cancer affected their mental health.
The link between ejaculation and prostate cancer explained.
People with low-risk prostate cancer are more likely to die from something else. Overdiagnosis and overtreatment can lead to life-changing complications.
Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.
There is no one-size-fits-all approach to treating cancer. Understanding how cancer cells evolve could help researchers develop more effective drugs.
A panel of experts has deemed the digital rectal examination to be inferior to MRI in monitoring prostate cancer in men.
There have only been around 200 reported cases of foreign accent syndrome since it was first reported in 1907.
The miracles of modern medicine can be life-saving. Yet as Tim Baker writes, cancer patients yearn for a little empathy from their doctors, as well as scripts.
Due to increasing concerns over the health hazards posed by BPA, the Food and Drug Administration plans to reevaluate the safety of the controversial chemical for use in everyday products.
New research shows five bacteria are associated with an increased risk of aggressive prostate cancer.
Eating less meat was also linked with a lower risk of colorectal, breast, and prostate cancer.
More 9/11 responders died from physical and mental health issues after the terrorist attacks than on the day itself. And survivors are still suffering 20 years later.
Cancer mortality has dropped in the US, due largely to lower smoking rates, as well as early detection and better treatments. These advances often do not extend to people in developing nations.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Men with faults in their BRCA2 gene are at higher risk of aggressive prostate cancer.
A recent study reported a high consumption of dairy products was associated with an increased risk of prostate cancer. But breaking down the results shows there’s no reason for men to give up dairy.
Private proton centres are targeting patients who might not see the most benefit from expensive treatments.
A step-by- step coordinated physiotherapy plan is key for patients with disorders related to the pelvic floor.
The threshold for diagnosing common conditions such as high blood pressure, chronic kidney disease and gestational diabetes have all lowered in recent years. But for whose benefit?
Top contributors
-
Head of Urology at Monash Medical Centre and Associate Professor of Surgery, Monash University
-
Professor of Medicine, Bond University
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Emeritus Professor in Public Health, University of Sydney
-
Research Fellow, Prostate Cancer Research Group, Monash University
-
Assistant Professor, Bond University
-
PhD student in Biology, University of Rochester
-
Professor of Surgery, Eastern Health Clinical School, Monash University
-
Professor of Family Medicine, University of Calgary
-
Associate Professor, University of Sydney
-
NHMRC Emerging Leader Research Fellow, University of Sydney
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, The University of Western Australia
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
Professor of Clinical Epidemiology, Bond University
-
Professor of Molecular Oncology, University of Bradford
